Five Nobel laureates are quietly orbiting Isomorphic Labs, the Alphabet-backed company trying to use artificial intelligence to end the world’s deadliest diseases. What they are building would have been science…
For decades, cardiac amyloidosis was a diagnosis cardiologists whispered and patients rarely heard. In 2026, tafamidis, acoramidis, RNA silencers, and a CRISPR gene editing therapy are transforming ATTR care and…
New glymphatic research reveals that deep slow wave sleep drives the brain’s nightly clearance of amyloid and tau, with 2026 data linking sleep architecture to long term dementia risk and…
A new wave of circadian biology research from Satchin Panda, Courtney Peterson, and the NIH is reshaping how scientists think about meal timing. Time-restricted eating influences glucose, blood pressure, autophagy,…
🔬 Senolytics Reduce Epigenetic Age: Lab data show senolytic compounds measurably lower biological age markers, with human pilot trials now exploring effects on mobility and cognition. 🧠FTL1 Protein Drives Memory Decline: Scientists identified a specific protein that weakens brain cell connections with age, opening a new therapeutic target for cognitive preservation. 🤖 Novo Nordisk + OpenAI Partnership: The pharma giant is applying frontier AI to compress drug discovery timelines and accelerate patient access to novel medicines. 🦠CAG-170 Bacteria Linked to Gut Health: A globally validated analysis found this rare bacterial group is a marker of health, producing B12 and stabilizing the gut ecosystem. 😴 Solar Jet Lag and Liver Cancer: A new federally backed study will probe whether circadian misalignment is an upstream cause of the most common form of liver cancer.
For the first time in pharmaceutical history, molecules designed almost entirely by artificial intelligence are surviving Phase 2 trials in real patients. From Insilico’s rentosertib to Isomorphic Labs’ multi-billion dollar…
Mitochondrial transplantation, once a fringe idea, is now being tested in human clinical trials for heart failure, stroke, and age-related cellular decline. A new wave of 2026 research shows that…
A Stanford University study of 44,498 people and 2,916 blood proteins has mapped the biological age of 11 organs and identified a startling finding: a biologically aged brain carries Alzheimer’s…
For decades, confirming Alzheimer’s disease required a spinal tap or a PET scan that few patients ever received. In 2025 the FDA cleared the first plasma p-tau217 blood test, and…
A landmark 2026 study in Nature Aging reveals that phosphoenolpyruvate (PEP), a glycolytic metabolite, acts as a natural brake on the cGAS-STING inflammatory pathway. As PEP levels decline with age,…
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.